Addressing challenges in mRNA drug development and manufacturing

Interactive Article

mRNA is being explored as a therapeutic strategy for a variety of clinical applications, including infectious disease, protein replacement, and immuno-oncology, among others.

But despite its inherent advantages, several challenges still exist, including:

  • Optimizing mRNA stability and protein expression
  • Developing production and purification processes
  • Designing an efficient therapeutic delivery vehicle
  • Balancing the innate immune system response
  • Obtaining the intended therapeutic response

Our interactive article explores each industry challenge in detail and examines avenues to overcome them.